Atrion develops and manufactures products, primarily for medical applications. Co. has developed various proprietary valves designed to fill, hold and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter and other applications in fields such as anesthesia and oncology. Co.'s primary cardiovascular products is the Myocardial Protection System, a proprietary technology that is used in open-heart surgery that delivers to the heart essential fluids and medications, mixes drugs and controls temperature, pressure and other variables. Co. also manufactures balloon catheters used in the treatment of nasolacrimal duct obstruction in children and adults. The ATRI stock yearly return is shown above.
The yearly return on the ATRI stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the ATRI annual return calculation with any dividends reinvested as applicable (on ex-dates).
|